Exencial Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.8M Sell
17,141
-262
-2% -$266K 0.49% 57
2025
Q4
$18.7M Sell
17,403
-5
-0% -$4.78K 0.59% 46
2025
Q3
$13.3M Buy
17,408
+11,396
+190% +$8.48M 0.43% 65
2025
Q2
$4.69M Sell
6,012
-904
-13% -$702K 0.17% 140
2025
Q1
$5.71M Buy
6,916
+390
+6% +$325K 0.21% 125
2024
Q4
$5.04M Sell
6,526
-265
-4% -$219K 0.18% 135
2024
Q3
$6.02M Sell
6,791
-70
-1% -$62.9K 0.22% 123
2024
Q2
$6.21M Sell
6,861
-354
-5% -$283K 0.23% 117
2024
Q1
$5.61M Sell
7,215
-239
-3% -$170K 0.21% 125
2023
Q4
$4.35M Buy
7,454
+286
+4% +$167K 0.18% 131
2023
Q3
$3.85M Sell
7,168
-656
-8% -$338K 0.19% 129
2023
Q2
$3.67M Buy
7,824
+38
+0.5% +$15.9K 0.17% 136
2023
Q1
$2.67M Sell
7,786
-539
-6% -$182K 0.14% 151
2022
Q4
$3.05M Buy
8,325
+3,557
+75% +$1.26M 0.16% 149
2022
Q3
$1.54M Sell
4,768
-18
-0.4% -$5.7K 0.09% 180
2022
Q2
$1.55M Buy
4,786
+611
+15% +$183K 0.09% 188
2022
Q1
$1.2M Buy
4,175
+1,275
+44% +$328K 0.06% 222
2021
Q4
$801K Buy
2,900
+251
+9% +$63.6K 0.04% 247
2021
Q3
$612K Sell
2,649
-9,271
-78% -$2.29M 0.03% 227
2021
Q2
$2.74M Buy
11,920
+9,916
+495% +$1.99M 0.15% 157
2021
Q1
$374K Sell
2,004
-10,094
-83% -$1.97M 0.02% 318
2020
Q4
$2.04M Sell
12,098
-12,350
-51% -$1.84M 0.14% 151
2020
Q3
$3.62M Buy
24,448
+23,044
+1,641% +$3.57M 0.19% 141
2020
Q2
$231K Buy
+1,404
New +$216K 0.02% 296

Other funds holding LLY

Exencial Wealth Advisors's LLY Position: Q1 2026 in Review

Exencial Wealth Advisors reduced its Eli Lilly (LLY) stake by 1.5% in Q1 2026, selling an estimated $266K and leaving 17,141 shares worth $15.8M. The position accounts for 0.49% of the portfolio, ranked #57.

Exencial Wealth Advisors first reported a position in LLY in Q2 2020 and has held it in 24 quarters since. The position peaked at $18.7M in Q4 2025. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Exencial Wealth Advisors held 17,141 shares of Eli Lilly worth $15.8M as of Q1 2026.
  • Exencial Wealth Advisors sold 262 Eli Lilly shares in Q1 2026, an estimated $266K.
  • Eli Lilly made up 0.49% of Exencial Wealth Advisors's portfolio in Q1 2026, its #57 holding.
  • Exencial Wealth Advisors first reported a position in Eli Lilly in Q2 2020 and has held it in 24 quarters since.
  • Exencial Wealth Advisors's Eli Lilly position peaked at $18.7M in Q4 2025.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Exencial Wealth Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.